PHCbi Launches LiCellGrow™ System to Boost Cell & Gene Therapy Manufacturing

PHC Corporation’s biomedical division PHCbi introduced the LiCellGrow™ cell expansion system designed to improve the quality, efficiency, and scalability of cell and gene therapy production by providing real‑time metabolic monitoring and automated culture control. The new platform aims to help developers overcome key manufacturing challenges and will be showcased at the 25th Congress of the Japanese Society for Regenerative Medicine.

Learn More